Although a substantial amount of LMP1 is actually located in endosomes and not accessible on the surface of EBV associated tumor cells for CAR recognition [87], NPC cells overexpressing LMP1 could be targeted by T cells transgenic for a LMP1 specific CAR [85,86]. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.